Raziel Therapeutics a clinical-stage pharmaceutical company announces a $22 million Series C preferred stock financing led by Pontifax, with the participation of existing investors Dr. Shmuel Cabilly

Concenter Biopharma is working on a novel drug to eliminate type 2 diabetes with no side effects. The drug dramatically lowers insulin resistance, the major

During the MEDICA exhibition in Düsseldorf, Germany, on November 18, Salignostics present for the first time the world’s first saliva rapid pregnancy test, the SaliStick. Salistick provides

Entera Bio‘s platform technology enables oral therapies based on molecules that would otherwise undergo gastric degradation and have limited or no bioavailability. By transforming injectable

Jerusalem based Pepticom, a leader in artificial intelligence peptide drug discovery,  has secured $5 million in Series A funding from the Chartered Group. Pepticom’s unique

Jerusalem-based Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, and Swiss Lonza (SWX: LONN), an integrated healthcare solutions provider, have entered into a strategic

Agreement Integrates Accellix’s Proprietary Quality Control Optic System, Cartridges, Reagents and Software into Orgenesis’ Point of Care Cellular Therapy Platform Orgenesis Inc. a leading cell

The European Commission managing Horizon 2020 – the EU Framework Programme for Research and Innovation –  approved HIL’s Phase-II proposal, at a total budget of

Atox Bio, a late-stage clinical company developing immunotherapies for critically ill patients,  announced that the Biomedical Advanced Research and Development Authority (BARDA) has exercised the